Nonresponse to treatment for hepatitis C: current management strategies.
about
Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis COccult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapyEvolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*Management of nonresponsive hepatitis C.Interfering with hepatitis C virus assembly in vitro using affinity peptides directed towards core protein.Structure and dynamics changes induced by 2,2,2-trifluoro-ethanol (TFE) on the N-terminal half of hepatitis C virus core protein.
P2860
Nonresponse to treatment for hepatitis C: current management strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonresponse to treatment for hepatitis C: current management strategies.
@en
Nonresponse to treatment for hepatitis C: current management strategies.
@nl
type
label
Nonresponse to treatment for hepatitis C: current management strategies.
@en
Nonresponse to treatment for hepatitis C: current management strategies.
@nl
prefLabel
Nonresponse to treatment for hepatitis C: current management strategies.
@en
Nonresponse to treatment for hepatitis C: current management strategies.
@nl
P2860
P1433
P1476
Nonresponse to treatment for hepatitis C: current management strategies.
@en
P2093
He-Jun Yuan
William M Lee
P2860
P356
10.2165/00003495-200868010-00003
P577
2008-01-01T00:00:00Z
P6179
1040710435